A 67-year-old woman is being treated for metastatic ovarian cancer with cisplatin and cyclophosphamide. To prevent nausea and vomiting, she is given an agent that selectively antagonizes 5-hydroxytryptamine-3 (5-HT3) receptors. Which of the following drugs is this patient most likely taking?
**Core Concept:** Cisplatin and cyclophosphamide are chemotherapeutic agents used in the treatment of ovarian cancer. They can cause nausea and vomiting as a side effect due to their inhibition of central and peripheral 5-hydroxytryptamine (serotonin) receptors, specifically 5-HT3 receptors. Selective antagonists of 5-HT3 receptors are used to prevent these side effects.
**Why the Correct Answer is Right:** The correct answer is a drug that selectively antagonizes 5-HT3 receptors to prevent chemotherapy-induced nausea and vomiting. In this case, the correct answer is a 5-HT3 receptor antagonist.
**Why Each Wrong Option is Incorrect:**
A. Olanzapine (Option A) is an atypical antipsychotic drug used for treating schizophrenia and bipolar disorder. Although it has some 5-HT3 antagonist properties, it is not specifically designed for preventing chemotherapy-induced nausea and vomiting.
B. Ondansetron (Option B) is a selective 5-HT3 receptor antagonist used to prevent and treat nausea and vomiting associated with chemotherapy.
C. Palonosetron (Option C) is another selective 5-HT3 receptor antagonist used to prevent nausea and vomiting associated with chemotherapy, including that of the patient's ovarian cancer treatment.
D. Granisetron (Option D) is a selective 5-HT3 receptor antagonist widely used for preventing chemotherapy-induced nausea and vomiting.
**Clinical Pearl:** Selective 5-HT3 receptor antagonists are a standard component of antiemetic regimens for patients receiving chemotherapy, including cisplatin and cyclophosphamide. They work by blocking the serotonin receptors involved in the emetic reflex, preventing the transmission of nausea and vomiting signals to the brain.
**Correct Answer Explanation:** Option C (Palonosetron) is the correct answer as it is a selective 5-HT3 receptor antagonist, like the other options (B, D, and C), but it is an older drug that was developed before selective 5-HT3 antagonists became widely available. Palonosetron is still used for this purpose, but other newer drugs like ondansetron, granisetron, and dolasetron are more commonly used for this purpose due to their superior pharmacokinetic and pharmacodynamic properties.
**Why Each Wrong Option is Incorrect:**
A. Olanzapine (Option A) is an atypical antipsychotic drug used for treating schizophrenia and bipolar disorder, not specifically for preventing chemotherapy-induced nausea and vomiting. Although it has some 5-HT3 antagonist properties, it is not the most effective drug in this class for this purpose.
Ensuring a comprehensive understanding of this question requires knowledge of the pharmacology of 5-HT3 receptor antagonists, their role in preventing chemotherapy-induced nausea and vomiting, and the development of newer drugs in this class.